STAT News

STAT+: GLP-1s are given an FDA warning for rare eye condition risk

The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”

By STAT News

1 min read
STAT+: GLP-1s are given an FDA warning for rare eye condition risk
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights